Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Large language models struggle with accurate clinical decision-making compared to real-world needs.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Topical minoxidil increases hair density in androgenetic alopecia but has unclear clinical significance.

A new method organizes drug information to improve data use and create a comprehensive drug database.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Machine learning can accurately predict PCOS phenotypes using lifestyle and symptom data.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Folicrex may help with hair growth and health but lacks clinical evidence.

AI can effectively predict COVID-19 mortality risk using patient data.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

HairLossMultinet accurately classifies hair damage with 98% accuracy but needs a more diverse dataset for broader use.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Platelet-rich plasma therapy's effectiveness for female hair loss needs more accurate data and further examination.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The book provides guidelines for using PRP and microneedling in skin treatments, despite limited scientific data.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Forsythiae Fructus has anti-inflammatory, antibacterial, and antiviral properties, with differences between unripe and ripe forms important for clinical use.

Hormonal dysfunctions, like PCOS, are common among reproductive-age women in India.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.